What Is Avian Flu?

Introduction

Avian influenza—often referred to as avian flu or bird flu—is a virus that has circulated among the world’s migratory birds for at least a century. However, in recent decades, new, highly pathogenic strains of the virus have wreaked havoc on certain bird populations, particularly poultry livestock, and become a growing threat to humans and other mammals.  

Since 2020, cases have been rising in other birds and in mammals that were not previously susceptible. The global surge in outbreaks has forced agriculture companies to cull millions of poultry, the most consumed meat in the world, and threatened some endangered species. Meanwhile, drawing on the harsh lessons of the COVID-19 pandemic, scientists and policymakers are raising concerns about the prospect of avian flu morphing into the next zoonotic pandemic.

What is avian flu?

First discovered in 1878, avian influenza is a viral disease that primarily infects birds, although some strains can spread to and kill mammals, including humans. The H5N1 strain, one of the most common today, was first identified in domestic waterfowl in 1996.

Birds. The flu mainly spreads asymptomatically among wild aquatic birds, but domestic poultry are also susceptible and can become extremely ill and die. Twenty-five known subtypes of avian flu have been identified in birds. There are two main categories: low pathogenicity, which often causes little-to-no signs of disease, and high pathogenicity, strains that cause severe disease and poultry mortality. Highly pathogenic strains of avian influenza have a 90 to 100 percent mortality rate among poultry. Most infected livestock die within forty-eight hours.

Humans. Human cases of bird flu are extremely rare, but often deadly. Most people who have been infected have usually been directly exposed to infected poultry or contaminated environments by them. Human-to-human transmission is believed to have only occurred in a few isolated instances, but sustained transmission between humans has not yet been identified. The two strains of avian flu that have killed the most people are H5N1 and H7N9. The first human cases of H5N1 were detected in China in 1997, but the bulk of cases came between 2003 and 2015, with Egypt as a hot spot. To date, there have been 882 human cases, with 461 deaths across nearly two dozen countries, according to World Health Organization (WHO) data. 

H7N9 was also first reported in China in 2013, and it has killed more than six hundred people to date. Some non-fatal cases are asymptomatic, but common effects can include flu-like symptoms, conjunctivitis (pink eye), pneumonia, multi-organ failure, seizures, and neurological damage. Newer strains that later evolved, such as H5N6 and H5N8, are also infecting humans. 

Other mammals. Since 2020, avian flu has been found in close to fifty mammal species across more than two dozen countries, considerably more widespread than past waves. The disease can often be deadly for mammals. There have been notable outbreaks in mink in Spain, seals in Peru, and even domestic cats and dogs in several countries. Most recently, at the beginning of 2024, H5N1 was found in seals in Antarctica for the first time. And as of March, avian flu was reportedly worsening in marine mammals at rates that have prompted scientists to become concerned about mammal-to-mammal transmission, which would represent a much more dangerous threat to the affected ecosystems. In April, the virus was detected in U.S. cattle for the first time, affecting herds in several states. At least one farm worker, in Texas, was also infected.  

Where is avian flu?

H5N1 began circulating in parts of Africa, Asia, and Europe in late 2021, but its reach has exploded since then: the virus has been recorded in more than eighty countries since 2022. There have been recent cases in all continents except for Australia. 

In the current wave, relentless outbreaks in poultry have wracked U.S. agriculture nationwide as well. Avian flu has been recorded in forty-eight states and affected more than eighty-two million poultry, as of March 2024. European countries witnessed a similar pattern of surging infections, affecting some fifty million poultry across thirty-seven countries, though France suffered the brunt of these. Other countries, such as Japan and South Africa, experienced their worst avian flu outbreaks among farmed birds.

What are the economic consequences of the outbreaks?

Avian flu outbreaks can cost farmers and consumers billions of dollars in lost profits and higher prices, and they disrupt important international trade. The ongoing avian flu outbreak in the United States, the world’s largest poultry meat producer and second-largest egg producer, caused economic losses around $2.5–3 billion by the end of 2023, and experts expect this cost will only rise amid new surges of the disease in 2024. Avian flu has led to the deaths or culling of more than eighty million poultry livestock. Per U.S. regulations, producers must cull all the birds in an infected flock, even if some of them do not have the disease. Amid the outbreak, the cost of a dozen eggs more than doubled to nearly five dollars in January 2023 before producers were able to restore their flocks. In recently infected cattle, U.S. farmers have reported reduced milk production, although it has had a limited effect on supplies thus far.  

The reduction of poultry has exacerbated food security in some parts of the world, particularly in lower-income countries where poultry products are a major source of protein. South Africa’s poultry industry underwent major supply shortages in 2023 as its worst avian flu outbreak added to its chronic power outages, which further hampered poultry production. Studies in Egypt have recorded stunted growth in youth coinciding with past avian flu outbreaks. 

Avian flu and the perceptions around it can also harm the global trade of poultry products. Amid a 2004 outbreak in the United States, for example, U.S. poultry exports dipped more than 20 percent after several countries imposed embargoes on U.S. poultry products. These trade constrictions also reduce incomes for producers whose flocks never even contracted the virus, as well as for others involved in the poultry value chain. These economic concerns have rendered several countries wary of vaccinating poultry for avian flu, as they do not want to risk potential embargoes from their trading partners.

What is driving the spread of avian flu?

The global spread is due in part to bird migration patterns, allowing infected birds to carry the disease thousands of miles to sites along their flyways. At the same time, the virus is increasingly mutating as it encounters new host animals and new species. 

Outbreaks in the past often subsided in the summer when bird migrations ceased, yet this was not the case in the recent H5N1 strain, which was some of the cause for scientists’ concern. The constant stream of outbreaks across the world in 2023 triggered concerns that avian flu could become a year-round threat. The reasoning for the virus’s persistence is still not fully clear, although some research has indicated that climate change and human activities are contributing factors. Climate change–related fluctuation in conditions such as temperature are altering the timing of some bird behaviors, including migration and breeding. Meanwhile, habitat destruction and urbanization are also affecting breeding site availability. The confluence of these factors drives birds from different parts of the world to come into contact with each other for the first time and interact with more habitats, both natural and urban. Such encounters expand the opportunities for the virus to spread and mutate. 

The corporate consolidation of U.S. factory farms, where poultry livestock are typically held in close quarters, also contributes to the rapid spread of the virus and mass poultry deaths. The environmental nonprofit Food and Water Watch said in a 2020 study [PDF] that 96 percent of U.S. chickens are raised under a production contract by major corporations, such as Tyson Foods or Perdue Farms.   

How significant is the threat to public health?

Human cases of avian flu are rare, and experts say the threat to public health is generally low. However, human cases have a high fatality rate, at more than 50 percent. (At its peak, for comparison, the global COVID-19 death rate was reported to be around 8 percent, though it is widely thought to be far higher.) Still, health experts are worried about the risks to farm workers who could be regularly exposed to infected animals. 

For a virus to have pandemic potential, it needs to be able to pass easily from person-to-person. H5N1 does not have the ability to do so, but scientists fear it could develop this feature. 

“The bigger picture is that this virus is not cooling off,” CFR Senior Fellow Jennifer Nuzzo told Politico. “We’ve been worrying about this virus for twenty years, more than twenty years. And in the last year, it has really been remarkable in how far across the globe it has been spreading, and how many species it’s been affecting.”

The WHO warns that the recent surge in avian flu outbreaks among mammals could increase the virus’s ability to circulate more easily among humans. As viruses quickly spread and evolve, they can more easily mutate and create new strains that are more effective at infecting people. In April 2024, the United States reported its second-ever case of H5N1, a human who became infected via sick dairy cattle in Texas, raising concerns of growing mammal-to-mammal transmission. Amid these latest outbreaks, the Centers for Disease Control and Prevention (CDC) is also recommending against the consumption of raw milk, which is sold legally in most states.

Countries such as Egypt and Indonesia experienced the brunt of human cases in the 2015 wave, and in the current wave, Cambodia and the United Kingdom have the highest numbers, which are much lower still than those seen in the prior outbreaks. Nonetheless, the ongoing bouts of avian flu in countries that have never experienced cases in mammals has evoked international attention. 

Can avian flu be contained?

The Food and Agriculture Organization (FAO), WHO, and World Organization for Animal Health (WOAH) are urging countries to work together across sectors to prevent both human and animal infections. Their recommendations include enhanced surveillance and information sharing; increased biosecurity measures, such as vaccinating livestock; restricted contact with other farms and equipment; and proper hygiene and disinfection of farm equipment and facilities. 

There are avian flu vaccines for humans and birds, but there are a number of challenges and uncertainties with both. For instance, there is global hesitancy over the bird vaccine for trade reasons, and the existing human vaccines are derived from previous strains, so it could take a while to develop new ones and implement them on a mass scale. Some countries fear that importing vaccinated birds will make conducting surveillance more difficult, as it will be harder to determine if birds have been infected or vaccinated. To some degree, there are concerns that importing eggs or meat from birds that have been vaccinated could inadvertently spread the disease within the importing country’s borders, though there is no evidence to suggest this is possible. 

Avian flu vaccines are mostly administered to birds in countries where the flu is endemic, and that have minimal poultry trade, such as Egypt, Indonesia, Mexico, and most recently, France. Commercial poultry in the United States receive other vaccinations, such as against fowlpox, but not yet for avian flu. The U.S. Department of Agriculture (USDA) is testing several bird vaccines but has not approved any, mostly over concerns that requiring a vaccine will harm trade. Despite this roadblock, experts have increasingly called for the U.S. government to launch a vaccination campaign for poultry, which they say would reduce the risk of spillover that could trigger a pandemic. Some poultry vaccines have proven to be as high as 94 percent effective. 

There is also a lot of uncertainty around the prospects of an avian flu vaccine for humans. Several major companies that manufacture them have said they could expedite the production of millions of doses in the event of a pandemic. The United States has an emergency stockpile of H5N1 vaccines, but experts have said that they would be insufficient if this particular strain were to start infecting people at a larger scale. Further, the shots have only been administered in trials and were derived from strains that circulated in 2004 and 2005. Some companies are working on developing vaccines that better match the highly pathogenic subvariant that is causing havoc today, but experts say it is unclear whether a human vaccine could be manufactured at a global scale while staying ahead of the curve on the virus’s rapid mutation. 

“We shouldn’t be overconfident in our ability to make vaccines that are safe and effective for avian flu because we’ve encountered challenges in the past with that antigen,” says CFR Fellow Luciana Borio. “Clinical trials involving H5N1 in the past have yielded lackluster results.”  

And as with many diseases, there is a global equity issue: these vaccines, which are not even past the testing phase, are already slated to go to richer countries first, leaving lower-income countries at risk. “We can’t do a repeat of what happened with COVID, where countries that were vaccine-producing waited until there was no more interest in vaccines in their populations before they really worked to consider the needs of developing countries and non-vaccine-producing countries,” Borio says.